Article information
Full text is only aviable in PDF
bibliografía
[1.]
F. Álvarez, E. Bouza, J.A. García-Rodríguez, M.A. Mayer, J. Mensa, E. Monsó, et al.
Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 38 (2002), pp. 81-89
[2.]
F. Álvarez, E. Bouza, J.A. García-Rodríguez, E. Monsó, J.J. Picazo, V. Sobradillo, et al.
Segundo documento de consenso sobre uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 39 (2003), pp. 274-282
[3.]
N.R. Anthonisen, J. Manfreda, P.W. Warren, E.S. Hershfield, G.K. Harding, N.A. Nelson.
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.
Ann Intern Med, 106 (1987), pp. 196-204
[4.]
S. Nouira, S. Marghli, M. Belghith, L. Besbes, S. Elatrous, F. Abroug.
Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.
Lancet, 358 (2001), pp. 2020-2025
[5.]
F. Baquero, J.A. García-Rodríguez, J. García, Aguilar L and the Spanish Surveillance Group for Respiratory Pathogens.
Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996–1997) multicenter surveillance study.
Antimicrob Agents Chemother, 43 (1999), pp. 357-359
[6.]
J.R. Lonks, J. Garau, L. Gómez, M. Xercavins, A. Ochoa de Echaguen, I.F. Gareen, et al.
Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin- resistant Streptococcus pneumoniae.
Clin Infect Dis, 35 (2002), pp. 556-564
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica
